BOS
GILD icon

Bank of Stockton’s Gilead Sciences GILD Stock Holding History

Bank of Stockton’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-6,108
Closed -$483K – 104
2016
Q3 		$483K Sell
6,108
-1,420
-19% -$115K 0.24% 65
2016
Q2 		$628K Buy
7,528
+565
+8% +$50.1K 0.33% 55
2016
Q1 		$640K Sell
6,963
-177
-2% -$16K 0.35% 56
2015
Q4 		$722K Buy
7,140
+530
+8% +$55.1K 0.41% 49
2015
Q3 		$649K Buy
6,610
+2,415
+58% +$268K 0.4% 49
2015
Q2 		$491K Buy
4,195
+1,315
+46% +$144K 0.27% 59
2015
Q1 		$283K Buy
+2,880
New +$292K 0.15% 89

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of Stockton's GILD Position: Q4 2016 in Review

Bank of Stockton sold out of Gilead Sciences (GILD) in Q4 2016, closing a stake of 6,108 shares — an estimated $483K sold.

Bank of Stockton first reported a position in GILD in Q1 2015 and held it in 7 quarters. The position peaked at $722K in Q4 2015. 1,573 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

  • Bank of Stockton reported no remaining Gilead Sciences position as of Q4 2016 after selling out during the quarter.
  • Bank of Stockton sold 6,108 Gilead Sciences shares in Q4 2016, an estimated $483K.
  • Bank of Stockton first reported a position in Gilead Sciences in Q1 2015 and held it in 7 quarters.
  • Bank of Stockton's Gilead Sciences position peaked at $722K in Q4 2015.
  • 1,573 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on Bank of Stockton's 13F filing for Q4 2016, filed 18 Jan 2017.